These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8241159)

  • 1. Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors.
    Zhao B; Winborne E; Minnich MD; Culp JS; Debouck C; Abdel-Meguid SS
    Biochemistry; 1993 Dec; 32(48):13054-60. PubMed ID: 8241159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor.
    Rose RB; Rosé JR; Salto R; Craik CS; Stroud RM
    Biochemistry; 1993 Nov; 32(46):12498-507. PubMed ID: 8241141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
    Veerapandian B; Cooper JB; Sali A; Blundell TL
    J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.
    Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A
    Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A check on rational drug design: crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitor.
    Hoog SS; Zhao B; Winborne E; Fisher S; Green DW; DesJarlais RL; Newlander KA; Callahan JF; Moore ML; Huffman WF
    J Med Chem; 1995 Aug; 38(17):3246-52. PubMed ID: 7650677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis.
    Abdel-Meguid SS; Zhao B; Murthy KH; Winborne E; Choi JK; DesJarlais RL; Minnich MD; Culp JS; Debouck C; Tomaszek TA
    Biochemistry; 1993 Aug; 32(31):7972-80. PubMed ID: 8347601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity.
    Hoog SS; Towler EM; Zhao B; Doyle ML; Debouck C; Abdel-Meguid SS
    Biochemistry; 1996 Aug; 35(32):10279-86. PubMed ID: 8756683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization and preliminary X-ray investigation of recombinant simian immunodeficiency virus proteinase.
    Wilderspin AF; Sugrue RJ
    J Mol Biol; 1993 Jun; 231(4):1139-42. PubMed ID: 8515473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations.
    Murthy KH; Winborne EL; Minnich MD; Culp JS; Debouck C
    J Biol Chem; 1992 Nov; 267(32):22770-8. PubMed ID: 1429626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.
    Mulichak AM; Hui JO; Tomasselli AG; Heinrikson RL; Curry KA; Tomich CS; Thaisrivongs S; Sawyer TK; Watenpaugh KD
    J Biol Chem; 1993 Jun; 268(18):13103-9. PubMed ID: 8514751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
    Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of drug resistant retroviral proteinase mutants.
    Good VM; Anderson MM; Baker JJ; Moloudi A; James CH; Wilderspin AF
    Biochem Soc Trans; 1997 Nov; 25(4):S633. PubMed ID: 9450061
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor.
    Priestle JP; Fässler A; Rösel J; Tintelnot-Blomley M; Strop P; Grütter MG
    Structure; 1995 Apr; 3(4):381-9. PubMed ID: 7613867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structures of HIV-1 and SIV protease product complexes.
    Rose RB; Craik CS; Douglas NL; Stroud RM
    Biochemistry; 1996 Oct; 35(39):12933-44. PubMed ID: 8841139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.
    Swain AL; Miller MM; Green J; Rich DH; Schneider J; Kent SB; Wlodawer A
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8805-9. PubMed ID: 2247451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere.
    Thompson SK; Murthy KH; Zhao B; Winborne E; Green DW; Fisher SM; DesJarlais RL; Tomaszek TA; Meek TD; Gleason JG
    J Med Chem; 1994 Sep; 37(19):3100-7. PubMed ID: 7932533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere.
    Kiso Y
    Biopolymers; 1996; 40(2):235-44. PubMed ID: 8785365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.